These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9821564)

  • 1. Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders.
    Nordahl TE; Stein MB; Benkelfat C; Semple WE; Andreason P; Zametkin A; Uhde TW; Cohen RM
    Biol Psychiatry; 1998 Nov; 44(10):998-1006. PubMed ID: 9821564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism in women with panic disorder.
    Bisaga A; Katz JL; Antonini A; Wright CE; Margouleff C; Gorman JM; Eidelberg D
    Am J Psychiatry; 1998 Sep; 155(9):1178-83. PubMed ID: 9734539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder.
    Kuikka JT; Pitkänen A; Lepola U; Partanen K; Vainio P; Bergström KA; Wieler HJ; Kaiser KP; Mittelbach L; Koponen H
    Nucl Med Commun; 1995 Apr; 16(4):273-80. PubMed ID: 7624108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy.
    Sakai Y; Kumano H; Nishikawa M; Sakano Y; Kaiya H; Imabayashi E; Ohnishi T; Matsuda H; Yasuda A; Sato A; Diksic M; Kuboki T
    Neuroimage; 2006 Oct; 33(1):218-26. PubMed ID: 16889985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants.
    Prasko J; Horácek J; Záleský R; Kopecek M; Novák T; Pasková B; Skrdlantová L; Belohlávek O; Höschl C
    Neuro Endocrinol Lett; 2004 Oct; 25(5):340-8. PubMed ID: 15580167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
    Cameron OG; Huang GC; Nichols T; Koeppe RA; Minoshima S; Rose D; Frey KA
    Arch Gen Psychiatry; 2007 Jul; 64(7):793-800. PubMed ID: 17606813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral glucose metabolism and memory in aged rhesus macaques.
    Eberling JL; Roberts JA; Rapp PR; Tuszynski MH; Jagust WJ
    Neurobiol Aging; 1997; 18(4):437-43. PubMed ID: 9330976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral glucose metabolism associated with a fear network in panic disorder.
    Sakai Y; Kumano H; Nishikawa M; Sakano Y; Kaiya H; Imabayashi E; Ohnishi T; Matsuda H; Yasuda A; Sato A; Diksic M; Kuboki T
    Neuroreport; 2005 Jun; 16(9):927-31. PubMed ID: 15931063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis.
    van den Heuvel OA; Veltman DJ; Groenewegen HJ; Witter MP; Merkelbach J; Cath DC; van Balkom AJ; van Oppen P; van Dyck R
    Arch Gen Psychiatry; 2005 Aug; 62(8):922-33. PubMed ID: 16061770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI; Swales PJ
    Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
    Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
    Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.
    Benkelfat C; Nordahl TE; Semple WE; King AC; Murphy DL; Cohen RM
    Arch Gen Psychiatry; 1990 Sep; 47(9):840-8. PubMed ID: 2393342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder.
    Bremner JD; Innis RB; White T; Fujita M; Silbersweig D; Goddard AW; Staib L; Stern E; Cappiello A; Woods S; Baldwin R; Charney DS
    Biol Psychiatry; 2000 Jan; 47(2):96-106. PubMed ID: 10664825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine for vestibular dysfunction in panic disorder: a prospective case series.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minnesota Multiphasic Personality Inventory correlates of panic disorder with agoraphobia: changes with treatment.
    Ito LM; Gorenstein C; Gentil V; Miyakawa E
    Braz J Med Biol Res; 1995 Sep; 28(9):961-5. PubMed ID: 8580883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic dizziness presenting in a patient with panic disorder: response to imipramine.
    Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
    Arq Neuropsiquiatr; 2009 Mar; 67(1):121-2. PubMed ID: 19330229
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral glucose metabolic differences in patients with panic disorder.
    Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
    Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.